MEDICINOVA, INC. Equity Method Investment, Ownership Percentage
MEDICINOVA, INC. (MNOV) had Equity Method Investment, Ownership Percentage of 50.00% as of 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2015-07-30
- 2014-12-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2014-08-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2013-12-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2012-03-31: Equity Method Investment, Ownership Percentage 30.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2014-12-31 | 50.00% 10-K · filed 2015-03-12 |
| 2014-08-31 | 50.00% 10-Q · filed 2015-07-30 |
| 2013-12-31 | 50.00% 10-Q · filed 2014-11-13 |
| 2012-03-31 | 30.00% 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |